Combined Association of Serum Uric Acid and Metabolic Syndrome with Chronic Kidney Disease in Hypertensive Patients

Background/Aims: Chronic kidney disease (CKD) is one of the major complications of hypertension. It is not only associated with the future burden of end-stage renal disease but also affects mortality and cardiovascular outcomes caused by hypertension. To help understand the pathogenesis and early pr...

Full description

Bibliographic Details
Main Authors: Haijiang Dai, Shijuan Lu, Xiaohong Tang, Minggen Lu, Ruifang Chen, Zhiheng Chen, Pingting Yang, Chang Liu, Honghao Zhou, Yao Lu, Hong Yuan
Format: Article
Language:English
Published: Karger Publishers 2016-06-01
Series:Kidney & Blood Pressure Research
Subjects:
Online Access:http://www.karger.com/Article/FullText/443443
_version_ 1818324315755511808
author Haijiang Dai
Shijuan Lu
Xiaohong Tang
Minggen Lu
Ruifang Chen
Zhiheng Chen
Pingting Yang
Chang Liu
Honghao Zhou
Yao Lu
Hong Yuan
author_facet Haijiang Dai
Shijuan Lu
Xiaohong Tang
Minggen Lu
Ruifang Chen
Zhiheng Chen
Pingting Yang
Chang Liu
Honghao Zhou
Yao Lu
Hong Yuan
author_sort Haijiang Dai
collection DOAJ
description Background/Aims: Chronic kidney disease (CKD) is one of the major complications of hypertension. It is not only associated with the future burden of end-stage renal disease but also affects mortality and cardiovascular outcomes caused by hypertension. To help understand the pathogenesis and early prevention of progressive CKD, this large-scale study is designed to determine the complex association between serum uric acid (SUA), metabolic syndrome and the prevalence of CKD in hypertensive patients. Methods: A total of 19,848 hypertensive subjects were enrolled in this cross-sectional study. Patients with proteinuria and/or an estimated glomerular filtration rate (eGFR) of 2 were considered CKD cases. Results: Hypertensive subjects with CKD had a higher prevalence of hyperuricemia and metabolic syndrome, as well as higher levels of SUA, BMI, waist circumference (WC), SBP, DBP, TG, fasting blood glucose and lower levels of HDL-C. Compared to patients without CKD, the multivariate-adjusted odds ratios [ORs, 95% confidence interval (CI)] for CKD patients were 2.30 (2.02-2.63) for hyperuricemia, 1.21 (1.04-1.41) for abdominal obesity, 1.21 (1.06-1.38) for elevated TG, 1.29 (1.06-1.56) for low HDL-C, 1.54 (1.36-1.75) for elevated fasting glucose, and 1.49 (1.30-1.71) for metabolic syndrome. Increasing SUA levels and number of individual metabolic syndrome components were associated with an increased prevalence of CKD. Compared with patients classified in the lowest SUA categories and with ≤1 metabolic syndrome components, subjects with HUA and 4 metabolic syndrome components had a 5.77-fold increased OR for CKD based on the multivariate-adjusted analysis. Conclusion: Both elevated SUA and metabolic syndrome are associated with an increased prevalence of CKD in hypertensive subjects. Subjects with higher SUA and sum of individual metabolic syndrome components simultaneously have a higher prevalence of CKD.
first_indexed 2024-12-13T11:26:38Z
format Article
id doaj.art-fe39e360fbcc4ba8a94135efc1d7a3bc
institution Directory Open Access Journal
issn 1420-4096
1423-0143
language English
last_indexed 2024-12-13T11:26:38Z
publishDate 2016-06-01
publisher Karger Publishers
record_format Article
series Kidney & Blood Pressure Research
spelling doaj.art-fe39e360fbcc4ba8a94135efc1d7a3bc2022-12-21T23:48:11ZengKarger PublishersKidney & Blood Pressure Research1420-40961423-01432016-06-0141441342310.1159/000443443443443Combined Association of Serum Uric Acid and Metabolic Syndrome with Chronic Kidney Disease in Hypertensive PatientsHaijiang DaiShijuan LuXiaohong TangMinggen LuRuifang ChenZhiheng ChenPingting YangChang LiuHonghao ZhouYao LuHong YuanBackground/Aims: Chronic kidney disease (CKD) is one of the major complications of hypertension. It is not only associated with the future burden of end-stage renal disease but also affects mortality and cardiovascular outcomes caused by hypertension. To help understand the pathogenesis and early prevention of progressive CKD, this large-scale study is designed to determine the complex association between serum uric acid (SUA), metabolic syndrome and the prevalence of CKD in hypertensive patients. Methods: A total of 19,848 hypertensive subjects were enrolled in this cross-sectional study. Patients with proteinuria and/or an estimated glomerular filtration rate (eGFR) of 2 were considered CKD cases. Results: Hypertensive subjects with CKD had a higher prevalence of hyperuricemia and metabolic syndrome, as well as higher levels of SUA, BMI, waist circumference (WC), SBP, DBP, TG, fasting blood glucose and lower levels of HDL-C. Compared to patients without CKD, the multivariate-adjusted odds ratios [ORs, 95% confidence interval (CI)] for CKD patients were 2.30 (2.02-2.63) for hyperuricemia, 1.21 (1.04-1.41) for abdominal obesity, 1.21 (1.06-1.38) for elevated TG, 1.29 (1.06-1.56) for low HDL-C, 1.54 (1.36-1.75) for elevated fasting glucose, and 1.49 (1.30-1.71) for metabolic syndrome. Increasing SUA levels and number of individual metabolic syndrome components were associated with an increased prevalence of CKD. Compared with patients classified in the lowest SUA categories and with ≤1 metabolic syndrome components, subjects with HUA and 4 metabolic syndrome components had a 5.77-fold increased OR for CKD based on the multivariate-adjusted analysis. Conclusion: Both elevated SUA and metabolic syndrome are associated with an increased prevalence of CKD in hypertensive subjects. Subjects with higher SUA and sum of individual metabolic syndrome components simultaneously have a higher prevalence of CKD.http://www.karger.com/Article/FullText/443443Chronic kidney diseaseSerum uric acidHyperuricemiaMetabolic syndromeHypertension
spellingShingle Haijiang Dai
Shijuan Lu
Xiaohong Tang
Minggen Lu
Ruifang Chen
Zhiheng Chen
Pingting Yang
Chang Liu
Honghao Zhou
Yao Lu
Hong Yuan
Combined Association of Serum Uric Acid and Metabolic Syndrome with Chronic Kidney Disease in Hypertensive Patients
Kidney & Blood Pressure Research
Chronic kidney disease
Serum uric acid
Hyperuricemia
Metabolic syndrome
Hypertension
title Combined Association of Serum Uric Acid and Metabolic Syndrome with Chronic Kidney Disease in Hypertensive Patients
title_full Combined Association of Serum Uric Acid and Metabolic Syndrome with Chronic Kidney Disease in Hypertensive Patients
title_fullStr Combined Association of Serum Uric Acid and Metabolic Syndrome with Chronic Kidney Disease in Hypertensive Patients
title_full_unstemmed Combined Association of Serum Uric Acid and Metabolic Syndrome with Chronic Kidney Disease in Hypertensive Patients
title_short Combined Association of Serum Uric Acid and Metabolic Syndrome with Chronic Kidney Disease in Hypertensive Patients
title_sort combined association of serum uric acid and metabolic syndrome with chronic kidney disease in hypertensive patients
topic Chronic kidney disease
Serum uric acid
Hyperuricemia
Metabolic syndrome
Hypertension
url http://www.karger.com/Article/FullText/443443
work_keys_str_mv AT haijiangdai combinedassociationofserumuricacidandmetabolicsyndromewithchronickidneydiseaseinhypertensivepatients
AT shijuanlu combinedassociationofserumuricacidandmetabolicsyndromewithchronickidneydiseaseinhypertensivepatients
AT xiaohongtang combinedassociationofserumuricacidandmetabolicsyndromewithchronickidneydiseaseinhypertensivepatients
AT minggenlu combinedassociationofserumuricacidandmetabolicsyndromewithchronickidneydiseaseinhypertensivepatients
AT ruifangchen combinedassociationofserumuricacidandmetabolicsyndromewithchronickidneydiseaseinhypertensivepatients
AT zhihengchen combinedassociationofserumuricacidandmetabolicsyndromewithchronickidneydiseaseinhypertensivepatients
AT pingtingyang combinedassociationofserumuricacidandmetabolicsyndromewithchronickidneydiseaseinhypertensivepatients
AT changliu combinedassociationofserumuricacidandmetabolicsyndromewithchronickidneydiseaseinhypertensivepatients
AT honghaozhou combinedassociationofserumuricacidandmetabolicsyndromewithchronickidneydiseaseinhypertensivepatients
AT yaolu combinedassociationofserumuricacidandmetabolicsyndromewithchronickidneydiseaseinhypertensivepatients
AT hongyuan combinedassociationofserumuricacidandmetabolicsyndromewithchronickidneydiseaseinhypertensivepatients